Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Anchisi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Swiss Medical Weekly|June 2, 2011
Sequential or concomitant chemotherapy in limited stage small-cell lung cancerKaouthar Khanfir, Mohamed Elhfidh, Sandro Anchisi, et al.
Cancer Biology & Therapy|March 27, 2023
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patientSandro Anchisi, Anita Wolfer, Bettina Bisig, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Journal of Geriatric Oncology|September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap studyGudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2013
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatmentDaniel C Betticher, Geoffrey Delmore, Urs Breitenstein, et al.
Cancer|August 9, 2024
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences studyVladimir Jolidon, Manuela Eicher, Isabelle Peytremann-Bridevaux, et al.
Swiss Medical Weekly|March 11, 2021
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate studySandro Tiziano Stoffel, Roger von Moos, Beat Thürlimann, et al.
Cancers|July 27, 2022
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap StudyRalf-Dieter Hofheinz, Sandro Anchisi, Birgit Grünberger, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN studySacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
BMC Cancer|February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Swiss Medical Weekly|June 2, 2011
Sequential or concomitant chemotherapy in limited stage small-cell lung cancerKaouthar Khanfir, Mohamed Elhfidh, Sandro Anchisi, et al.
Cancer Biology & Therapy|March 27, 2023
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patientSandro Anchisi, Anita Wolfer, Bettina Bisig, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Journal of Geriatric Oncology|September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap studyGudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2013
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatmentDaniel C Betticher, Geoffrey Delmore, Urs Breitenstein, et al.
Cancer|August 9, 2024
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences studyVladimir Jolidon, Manuela Eicher, Isabelle Peytremann-Bridevaux, et al.
Swiss Medical Weekly|March 11, 2021
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate studySandro Tiziano Stoffel, Roger von Moos, Beat Thürlimann, et al.
Cancers|July 27, 2022
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap StudyRalf-Dieter Hofheinz, Sandro Anchisi, Birgit Grünberger, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN studySacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
BMC Cancer|February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Pageof 4